Rapid-Onset Drug-Induced Liver Injury Following Amoxicillin-Clavulanate: A Case Report

Shuvam Khadka1, Abinash Dev1, Pramodman Singh Yadav2

  • 1B.P. Koirala Institute of Health Sciences Dharan Nepal.

Clinical Case Reports
|December 10, 2025
PubMed

Insights

Drug-Induced Liver Injury (DILI) from Amoxicillin-Clavulanate (A-C) is serious. This case highlights an unusually rapid DILI onset after only two doses, differing from typical presentations.

Area of Science:

  • Pharmacology
  • Hepatology
  • Clinical Toxicology

Background:

  • Drug-Induced Liver Injury (DILI) is a rare adverse effect of medications.
  • Amoxicillin-Clavulanate (A-C) is a common cause of idiosyncratic DILI, particularly in Western populations.
  • DILI cases are less frequently reported in some regions, and diagnosis requires a high index of suspicion.

Purpose of the Study:

  • To report a case of atypically rapid onset DILI.
  • To highlight the potential for rapid liver injury from Amoxicillin-Clavulanate.
  • To emphasize the importance of considering DILI even with short-term antibiotic exposure.

Main Methods:

  • Case report of a 32-year-old female patient.
  • Review of clinical presentation and medication history.
  • Diagnosis of DILI based on exclusion criteria and temporal relationship to A-C administration.

Main Results:

  • The patient experienced liver injury after only two doses of Amoxicillin-Clavulanate.
  • This onset is significantly faster than the typical presentation of DILI (days to weeks).
  • The case demonstrates an atypical, rapid-onset idiosyncratic reaction to A-C.

Conclusions:

  • Amoxicillin-Clavulanate can cause rapid DILI, challenging typical onset expectations.
  • Clinicians should maintain a high suspicion for DILI, irrespective of the duration of A-C use.
  • This case underscores regional variations in DILI reporting and presentation.

Related Concept Videos

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
217
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
169
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
236
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.3K
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.5K